Manuel Menéndez: Call for Contributions: New Book on Intrathecal Drug Delivery in the NEUROMETHODS Series by Springer Nature

I am pleased to announce that I am editing a new volume titled "Intrathecal Drug Delivery", which will be published as part of the NEUROMETHODS series by Springer Nature. This book aims to provide a comprehensive and cutting-edge overview of intrathecal drug delivery, covering clinical applications, technological advancements, and experimental approaches.

We are currently assembling a diverse group of international experts in neurology, neurosurgery, anesthesiology, biomedical engineering, and related fields to contribute chapters to this volume. If you or a colleague are working on intrathecal drug delivery and would like to contribute, we invite you to express your interest!

Topics Already Confirmed in the Book Include:

✅ Existing and upcoming intrathecal drugs
✅ Parameters influencing drug distribution in the CSF
✅ Continuous and controlled intrathecal drug delivery
✅ Intrathecal drug delivery for chronic pain
✅ Investigating intrathecal treatment of leptomeningeal disease
✅ Pumpless implantable devices for intrathecal pseudodelivery of drugs
... and more!

Who Should Contribute?

We are looking for researchers, clinicians, and industry professionals with expertise in:
🔹 Neurology and Neurosurgery
🔹 Pain Medicine and Anesthesiology
🔹 Biomedical Engineering and Drug Delivery Systems
🔹 Neuropharmacology and Experimental Models of Intrathecal Therapies

Key Information for Authors:

📌 Manuscript submission deadline: May 31, 2025
📌 Chapter length: ~30–60 pages
📌 No cost for authors – Springer covers all publishing expenses
📌 Figures (including color images) are free of charge
📌 Global visibility – Springer Nature ensures high discoverability

If you are interested in contributing or know someone who might be a good fit, please reach out to me! This is a great opportunity to showcase your work in an internationally recognized book series.

Let’s shape the future of intrathecal drug delivery research together! 🚀

For inquiries or to propose a chapter, contact me at: menendezgmanuel @ uniovi.es

📢 Please share this post with colleagues who might be interested!

#IntrathecalDrugDelivery #Neuropharmacology #Neurosurgery #Neurology #PainMedicine #BiomedicalEngineering #DrugDelivery #SpringerNature #NEUROMETHODS #MedicalResearch

My affiliation and interests

I am a neurologist (at Hospital Universitario Central de Asturias, Oviedo) and professor of neurology (at Oviedo University) with research experience in clinical and translational neuroscience (at Oviedo University and at Instituto de Investigación Sanitaria del Principado de Asturias). I am focused on exploring the 360º panoramic of neurodegenerative diseases: from neuropsychology to neuroimaging and from neurogenetics to phenotypes. In the last few years, I have been particularly interested in understanding the molecular mechanisms of neurodegeneration: genes, RNA, and proteins; and in studying brain clearance systems and the molecular dynamics between cells, the interstitial fluid, and the cerebrospinal fluid. I am also interested in developing new systems for targeted drug delivery to the CNS.

Liquorpheresis

Liquorpheresis, also known as cerebrospinal fluid (CSF) exchange, CSF filtration, or CSF apheresis, is a medical procedure designed to remove and replace cerebrospinal fluid. This technique treats certain neurological conditions by filtering out harmful substances or altering the composition of the CSF.

Key Points:

Procedure: During liquorpheresis, CSF is withdrawn from the patient and processed through a device that removes specific components (such as antibodies, immune complexes, or toxins). The filtered CSF or a substitute fluid is then returned to the intrathecal space.
Indications: Liquorpheresis is primarily used for conditions where harmful substances in the CSF need to be removed or reduced. These conditions might include certain autoimmune diseases, infections, or neuroinflammatory disorders.
Benefits: By directly modifying the CSF, liquorpheresis can rapidly reduce the concentration of pathological substances, potentially leading to quicker symptom relief and improved outcomes in conditions where these substances play a critical role.
Risks and Considerations: As with any invasive procedure, risks include infection, bleeding, and potential complications from the fluid exchange. The benefits must be weighed against these risks on a case-by-case basis.

Clinical Applications:

Liquorpheresis is still a relatively specialized and less common procedure compared to other apheresis techniques. However, it holds the potential for treating a range of neurological disorders, particularly those involving pathogenic factors within the CSF.

In summary, liquorpheresis is a procedure that involves removing and replacing cerebrospinal fluid to treat neurological conditions. It filters out harmful substances and potentially improves patient outcomes.

Pages

Call for Contributions: New Book on Intrathecal Drug Delivery in the NEUROMETHODS Series by Springer Nature

Topics Already Confirmed in the Book Include:

Who Should Contribute?

Key Information for Authors:

Neurodiagnoses.com

Others